Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)

NCT01891981 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
16
Enrollment
OTHER
Sponsor class

Stopped Ph I Exempt as it did not proceed to the Phase II terminated early by the supporter

Conditions

Interventions

Sponsor

M.D. Anderson Cancer Center

Collaborators